Templeton Emerging Markets IT PLC
22 March 2007
TEMPLETON EMERGING MARKETS INVESTMENT TRUST PLC
(The 'Company')
The following is the text of a letter being posted to shareholders today.
"Dear Shareholder
Update on Consultation with Shareholders
You will know that the Board has been conducting a consultation exercise with
its shareholders about the level of discount on the Company's shares and
possible methods of addressing this discount. The Board has also taken advice
from its advisors ING and UBS.
The extensive consultation with shareholders was achieved in three ways. First
we made direct contact with all the Company's major shareholders. Many gave
time to meet with me and one or more of my Board colleagues face to face. Some
comments were also given to the Board through the Company's brokers. Secondly,
a number of you were good enough to attend a public meeting in London when you
let us have your views. Thirdly, a number of you who were unable to attend the
public meeting wrote to me either in letter form or by e-mail. All this
communication has been invaluable to us in our deliberations. In total, contact
was made with some two thirds of the share register and I personally saw or
spoke to shareholders representing over 57% of the Company's register.
As you might expect a range of views emerged but the principal themes were:
1. A majority of shareholders wanted the Company to introduce discount
control measures in some form and to use its existing buy back powers more
extensively.
2. A majority of shareholders valued the liquidity of the Company's shares
in the market and did not want that compromised.
3. Shareholders wanted the Company to continue as an investment trust.
4. A majority of shareholders did not perceive investment performance to be
a key issue in the Board's consideration of discount control.
After reflecting upon shareholder views and having conducted a detailed review
of all the options with our advisors, the Board has decided to bring forward
proposals which will provide those shareholders who wish to dispose of a
proportion of their shares with an opportunity to do so, but in a manner and at
a price which will not disadvantage those shareholders who wish to retain their
shares. This will be accompanied by a more active use of the Company's buy back
powers. Such proposals will be implemented in the interests of all shareholders
to enhance the NAV per share.
The Board's proposals will be subject to the preparation of detailed shareholder
documentation, and it is envisaged that the proposals will require
shareholders' approval in a general meeting, as well as necessary regulatory
approvals.
The detailed terms of the proposals have yet to be finalised. The Board intends
to write to shareholders again shortly.
Yours faithfully
Sir Ronald Hampel
Chairman"
ENQUIRIES:
ING Corporate Finance: +44 (0) 20 7767 1000
Nicholas Gold
William Marle
Franklin Templeton Investments:
Client Dealer Services Freephone 0800 305 306 or +44 (0) 20 7073 8690
Sara MacIntosh +44 (0) 131 242 4000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.